Context: Recently listed mainboard IPO – Turtlemint Fintech Solutions Ltd (TURTLEMINT), a tech‑enabled insurance distribution (insurtech) platform.

1. Listing and near‑term setup

- IPO size ~₹883 crore (fresh ~₹661 cr + OFS ~₹222 cr), price band ₹144–152.(iporise.com)

- Subscription was modest: overall ~1.2x, with QIBs subscribed, retail just over 1x and NIIs under‑subscribed.(iporise.com)

- Listed on 29 June 2026 at a discount: ~₹134.9 on NSE (‑11.25% vs ₹152 issue) and ~₹136.2 on BSE (‑10.4%).(iporise.com)

- On listing day it traded roughly in the ₹136–147 range and was still ~6% below issue by close.(iporise.com)

- Recent GMP has been around zero/negative, indicating no strong speculative premium.(iporise.com)

I do not have live tick‑by‑tick data; for the latest price and volumes, please check the quote page on NSE/BSE or portals like Moneycontrol / IPO‑tracking sites.

2. Business model – positives

- Tech‑enabled insurance distribution platform connecting customers, “Digital Partners” (PoSP advisors) and insurers in a phygital model.(chittorgarh.net)

- Very large advisor network (PoSP / Digital Partners), among the largest in its peer group; operations spread across ~98% of India’s pin codes, with ~2+ crore policies distributed and over ₹10,000 cr of premiums facilitated over recent years.(chittorgarh.net)

- Product mix covers motor, health, life and other general insurance through tie‑ups with ~45 insurer partners.(chittorgarh.net)

- Asset‑light, scalable model with proprietary tech; IPO proceeds earmarked mainly for tech & cloud infra, product/engineering salaries, marketing, expansion of broking subsidiary (TIB), acquisitions and general corporate purposes.(chittorgarh.net)

Structurally, this is a play on rising insurance penetration + advisor‑led distribution, not on lending or pure payments.

3. Financial profile (FY23–FY25)

(Restated consolidated financials from the IPO note/prospectus)

- Total income:

- FY23: ~₹460 cr

- FY24: ~₹119 cr (sharp drop due to business restructuring / consolidation effects)

- FY25: ~₹693 cr (strong rebound).(chittorgarh.net)

- Profitability:

- EBITDA margins deep negative: around –59% (FY23), –144% (FY24), improving to around –23% (FY25).

- Net losses: ~₹288 cr (FY23), ~₹193 cr (FY24), ~₹194 cr (FY25).(chittorgarh.net)

- Net worth fell from ~₹743 cr (FY23) to ~₹410 cr (FY25), reflecting continued losses.(chittorgarh.net)

In short: strong top‑line scale and recovery in FY25, but the business is still firmly loss‑making with negative operating and net margins.

4. Valuation picture (at IPO levels)

- At the upper band (₹152), the IPO implied market cap was a little over ₹4,500 cr.(moneycontrol.com)

- Based on FY25 revenue (~₹660–693 cr), this works out to roughly 6.5–6.8x FY25 revenue for a company with:

- Negative EPS (~‑₹7.3),

- Very negative RoNW (~‑47%).(chittorgarh.net)

- Brokerage IPO notes generally flagged this revenue multiple as rich for a loss‑making, high‑cash‑burn model, and at least one note explicitly carried an “Avoid” stance at IPO time.(chittorgarh.net)

There is no perfect listed peer; PB Fintech (Policybazaar) is the closest benchmark, but operates at a much larger revenue scale and has already turned RoNW positive, so investors should be cautious comparing purely on P/S multiples.(chittorgarh.net)

5. Key risks and monitorables

- Path to profitability:

- Payouts/commissions to Digital Partners are a very high share of total expenses (around 70–77%). Profitability is heavily dependent on scale and operating leverage eventually offsetting these payouts and high tech/marketing spends.(chittorgarh.net)

- Business concentration:

- Heavy dependence on motor and general insurance; any slowdown or pricing pressure there can hit growth.

- Revenue is concentrated among a limited set of insurer partners. Loss of a few key relationships would hurt volumes.(chittorgarh.net)

- Regulatory and compliance risk:

- Insurance distribution is tightly regulated by IRDAI; rule changes on PoSPs, commission caps, data protection or KYC could impact the business model.

- As a digital platform handling sensitive customer data, it is exposed to cyber‑security and data‑privacy risks.(chittorgarh.net)

- Execution post‑IPO:

- Need to show consistent revenue growth without proportionate increase in losses.

- Integration and performance of the acquired broking subsidiary (TIB) and how effectively IPO funds get deployed into tech/brand building.

6. Overall analytical view (not a buy/sell call)

- The franchise strength (large PoSP network, wide insurer tie‑ups, nationwide reach) and sector tailwind (low insurance penetration, digital adoption) are clear positives.

- However, at IPO pricing the stock came with:

- Ongoing, sizeable losses,

- Negative RoNW and shrinking net worth,

- A revenue multiple (~6.5–6.8x FY25) that many analysts flagged as demanding for a model that still needs to prove profitability.(chittorgarh.net)

- The discount listing and flat/negative GMP suggest that broader market appetite is cautious, at least in the short term.

Illustrative approaches (for different risk profiles – examples only):

- Example 1 – Profitability‑focused investor: may prefer to wait for 2–3 quarterly results post‑listing to see if revenue growth sustains and losses narrow meaningfully before considering any exposure.

- Example 2 – High‑risk growth investor: may treat it as a long‑term, high‑beta insurtech bet, but would typically:

- Track how quickly sales grow vs. marketing/partner payout costs, and

- Look for any valuation comfort from deeper corrections below IPO‑implied sales multiples, instead of chasing immediately after listing.

This is purely informational analysis based on publicly available data and research reports; it is not investment advice. Please use it along with your own risk profile, time horizon and advisor’s inputs.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com